Skip to content

A Study on the Prevalence of Obstructive Sleep Apnea in Patients With Type II Diabetes Mellitus

Prevalence and Recognition of Obstructive Sleep Apnea in Chinese With Type 2 Diabetes Mellitus

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01172093
Enrollment
177
Registered
2010-07-29
Start date
2007-01-31
Completion date
2008-12-31
Last updated
2010-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Obstructive Sleep Apnea

Keywords

obstructive sleep apnea, prevalence, diabetes mellitus, Chinese

Brief summary

OSA is prevalent among patients with type II DM

Detailed description

Obstructive sleep apnea (OSA) has been reported to be common (prevalence ranged from 23-86%) in previous studies involving Caucasian diabetic patients. The investigators aim at finding out the prevalence of OSA in Chinese diabetic patients and identify the clinical predictors associated with OSA. Recruited subjects will undergo overnight polysomnography, anthropometric measurements, blood tests including glycosylated hemoglobin, renal function, glucose level, blood pressure measurement both during the clinic visit and after admission for in-laboratory sleep study.

Interventions

None listed

Sponsors

The University of Hong Kong
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients, age 18 - 75, with type 2 diabetes mellitus, including those on diet, on oral-hypoglycaemic agents or on insulin * Patients who are able to give written consent to undergo polysomnography

Exclusion criteria

* Patients who are unable or unwilling to give written consent to participate in the study * Patients with unstable medical illness or poor functional performance * Patients with recent myocardial infarction or hospital admission for congestive heart failure or cardiac arrhythmia in the past three months * Patients on renal replacement therapy for diabetic nephropathy or chronic renal failure, or plan to start renal replacement therapy in the coming six months * Patients suffered from recent stroke in the past six months or previous history of stroke with significant focal neurological deficit * Patients with type I diabetes * Pregnant lady or lactating women

Design outcomes

Primary

MeasureTime frameDescription
presence of OSAmeasured at a single time point during the recruitment period(2007-08), by polysomnographyThe diagnosis of OSA will be confirmed with polysomnography

Secondary

MeasureTime frameDescription
severity of OSAmeasured at a single time point during the recruitment period(2007-08), by polysomnographyThe severity of OSA will be assessed in terms of apnea hypopnea index, minimal oxygen saturation, duration of desaturation, arousal index during polysomnography
glycemic controlmeasured at a single time point, when the subjects were admitted for polysomnography (during 2007-08)by measuring glycosylated hemoglobin, blood glucose level

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026